About SPB

Swiss Plasmabiotech GmbH

Swiss Plasmabiotech is a biotechnology company based in Schwerzenbach near Zurich.

The company develops, produces, and distributes patented PRP products for autologous blood plasma therapy in regenerative medicine.

Plasmabiotech is a biotech company with an innovative vision and dedication to developing new products in the field of regenerative medicine.

Core Values

Leadership & Management

The company consists of an experienced and well-balanced team with complementary competencies. Chairman and Chief Executive Officer is Ihsan Yalcin, an internationally oriented leader with extensive experience in developing business strategies and global management. He holds sound academic qualifications in economics and international business, as well as many years of experience in international markets.

Vision & Mission

People are at the center of everything we do. We strive to make a difference in the field of regenerative medicine for the benefit of patients. With expertise, care, and perseverance, we aim to be a leading provider of products for autologous plasma therapy. We focus on comprehensive, future-oriented services that create a solid foundation for long-term business relationships.

Quality & Reliability

Quality is not just a standard for us, but part of our daily commitment. Our PRP system is certified according to EN ISO 13485 and bears the CE mark as a medical device. As part of the current regulatory transition period, the product is classified as a Class IIa medical device under Directive 93/42/EEC (MDD) and is being transitioned to Regulation (EU) 2017/745 (MDR), under which it is intended to be classified as Class IIb. The plasma obtained with the system can be applied directly into the body after centrifugation. Manufacturing is also carried out in compliance with GMP standards.
Locations

We are internationally represented

Over 40 Countries

figure